phenelzine has been researched along with Anankastic Personality in 17 studies
Phenelzine: One of the MONOAMINE OXIDASE INHIBITORS used to treat DEPRESSION; PHOBIC DISORDERS; and PANIC.
Excerpt | Relevance | Reference |
---|---|---|
"It is now well documented that fluoxetine is a viable treatment option for patients with obsessive-compulsive disorder (OCD), and there is a small body of evidence indicating that monoamine oxidase inhibitors may be effective in at least a subset of patients." | 9.08 | Placebo-controlled trial of fluoxetine and phenelzine for obsessive-compulsive disorder. ( Baer, L; Buttolph, ML; Jenike, MA; Minichiello, WE; Rauch, SL, 1997) |
"A double-blind clinical trial of clomipramine versus phenelzine was carried out on 30 patients suffering from DSM-III obsessive-compulsive disorder." | 9.07 | Clomipramine versus phenelzine in obsessive-compulsive disorder. A controlled clinical trial. ( Bulbena, A; Marcos, T; Menchón, JM; Olivares, J; Vallejo, J, 1992) |
"Leukopenia, a rare but serious side effect of many psychotropic agents including monoamine oxidase inhibitors (MAOIs), has not been reported in the literature in association with phenelzine." | 7.67 | A case report of leukopenia associated with phenelzine. ( Gilman, HE; Russakoff, LM; Tipermas, A, 1984) |
"It is now well documented that fluoxetine is a viable treatment option for patients with obsessive-compulsive disorder (OCD), and there is a small body of evidence indicating that monoamine oxidase inhibitors may be effective in at least a subset of patients." | 5.08 | Placebo-controlled trial of fluoxetine and phenelzine for obsessive-compulsive disorder. ( Baer, L; Buttolph, ML; Jenike, MA; Minichiello, WE; Rauch, SL, 1997) |
"A double-blind clinical trial of clomipramine versus phenelzine was carried out on 30 patients suffering from DSM-III obsessive-compulsive disorder." | 5.07 | Clomipramine versus phenelzine in obsessive-compulsive disorder. A controlled clinical trial. ( Bulbena, A; Marcos, T; Menchón, JM; Olivares, J; Vallejo, J, 1992) |
"Leukopenia, a rare but serious side effect of many psychotropic agents including monoamine oxidase inhibitors (MAOIs), has not been reported in the literature in association with phenelzine." | 3.67 | A case report of leukopenia associated with phenelzine. ( Gilman, HE; Russakoff, LM; Tipermas, A, 1984) |
"Isocarboxazid was replaced by placebo, using double-blind procedure." | 2.67 | Efficacy of combined antidepressant therapy in resistant neurotic disorder. ( Murphy, S; Tyrer, P, 1990) |
" Administering the monoamine oxidase inhibitor phenelzine in high dosage led to complete alleviation of his depression in 10 weeks, and 3 weeks afterwards the OCN was markedly improved." | 1.27 | A remarkable response of chronic severe obsessive-compulsive neurosis to phenelzine. ( Mahgoub, OM, 1987) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 10 (58.82) | 18.7374 |
1990's | 5 (29.41) | 18.2507 |
2000's | 1 (5.88) | 29.6817 |
2010's | 1 (5.88) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Mahgoub, N | 1 |
Asemota, B | 1 |
Alexopoulos, GS | 1 |
Tipermas, A | 1 |
Gilman, HE | 1 |
Russakoff, LM | 1 |
Jenike, MA | 2 |
Surman, OS | 1 |
Cassem, NH | 1 |
Zusky, P | 1 |
Anderson, WH | 1 |
Davis, JM | 1 |
Nasr, S | 1 |
Spira, N | 1 |
Vogel, C | 1 |
Isberg, RS | 1 |
Baer, L | 1 |
Minichiello, WE | 1 |
Rauch, SL | 1 |
Buttolph, ML | 1 |
Golwyn, DH | 1 |
Sevlie, CP | 1 |
Koran, LM | 1 |
Leventhal, JL | 1 |
Fireman, B | 1 |
Jacobson, A | 1 |
Vallejo, J | 1 |
Olivares, J | 1 |
Marcos, T | 1 |
Bulbena, A | 1 |
Menchón, JM | 1 |
Carrasco, JL | 1 |
Hollander, E | 1 |
Schneier, FR | 1 |
Liebowitz, MR | 1 |
Tyrer, P | 1 |
Murphy, S | 1 |
Pascual, J | 1 |
Combarros, O | 1 |
Berciano, J | 1 |
Baxter, LR | 1 |
Thompson, JM | 1 |
Schwartz, JM | 1 |
Guze, BH | 1 |
Phelps, ME | 1 |
Mazziotta, JC | 1 |
Selin, CE | 1 |
Moss, L | 1 |
Mahgoub, OM | 1 |
Jacobson, JN | 1 |
Jain, VK | 1 |
Swinson, RP | 1 |
Thomas, JG | 1 |
Annesley, PT | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
Clinical, Neurocognitive and Neuroimaging Variables Associated With Response to Treatment in Patients With OCD[NCT03993535] | Phase 4 | 250 participants (Actual) | Interventional | 2018-10-10 | Active, not recruiting | ||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
4 trials available for phenelzine and Anankastic Personality
Article | Year |
---|---|
Anxiety: differential diagnosis and treatment from a biologic perspective.
Topics: Agoraphobia; Anxiety Disorders; Clinical Trials as Topic; Diagnosis, Differential; Diazepam; Double- | 1981 |
Placebo-controlled trial of fluoxetine and phenelzine for obsessive-compulsive disorder.
Topics: Adult; Drug Administration Schedule; Female; Fluoxetine; Humans; Male; Monoamine Oxidase Inhibitors; | 1997 |
Clomipramine versus phenelzine in obsessive-compulsive disorder. A controlled clinical trial.
Topics: Adult; Clomipramine; Depressive Disorder; Dexamethasone; Dose-Response Relationship, Drug; Double-Bl | 1992 |
Efficacy of combined antidepressant therapy in resistant neurotic disorder.
Topics: Adult; Amitriptyline; Anxiety Disorders; Clinical Trials as Topic; Depressive Disorder; Diazepam; Do | 1990 |
13 other studies available for phenelzine and Anankastic Personality
Article | Year |
---|---|
The effect of riluzole augmentation in a patient with treatment-resistant obsessive-compulsive disorder, taking two other glutaminergic agents.
Topics: Adult; Clonazepam; Drug Therapy, Combination; Excitatory Amino Acid Antagonists; Fructose; GABA Modu | 2011 |
A case report of leukopenia associated with phenelzine.
Topics: Adult; Depressive Disorder; Female; Humans; Leukopenia; Obsessive-Compulsive Disorder; Phenelzine | 1984 |
Monoamine oxidase inhibitors in obsessive-compulsive disorder.
Topics: Adult; Anxiety Disorders; Female; Humans; Male; Middle Aged; Obsessive-Compulsive Disorder; Panic; P | 1983 |
A comparison of phenelzine and imipramine in an obsessive-compulsive patient.
Topics: Female; Humans; Imipramine; Middle Aged; Obsessive-Compulsive Disorder; Phenelzine | 1981 |
Fluoxetine versus phenelzine in obsessive-compulsive disorder.
Topics: Antidepressive Agents; Controlled Clinical Trials as Topic; Drug Administration Schedule; Fluoxetine | 1999 |
Pharmacotherapy of obsessive-compulsive disorder in a health maintenance organization.
Topics: Adolescent; Adult; Antidepressive Agents; California; Child; Drug Therapy; Female; Humans; Male; Med | 2000 |
Treatment outcome of obsessive compulsive disorder with comorbid social phobia.
Topics: Adult; Clomipramine; Comorbidity; Female; Fluoxetine; Fluvoxamine; Humans; Male; Middle Aged; Obsess | 1992 |
Partial status epilepticus following single low dose of chlorimipramine in a patient on MAO-inhibitor treatment.
Topics: Adult; Clomipramine; Humans; Male; Obsessive-Compulsive Disorder; Phenelzine; Status Epilepticus | 1987 |
Trazodone treatment response in obsessive-compulsive disorder--correlated with shifts in glucose metabolism in the caudate nuclei.
Topics: Adult; Blood Glucose; Caudate Nucleus; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; | 1987 |
A remarkable response of chronic severe obsessive-compulsive neurosis to phenelzine.
Topics: Adult; Chronic Disease; Humans; Male; Obsessive-Compulsive Disorder; Phenelzine | 1987 |
Anorgasmia caused by an MAOI.
Topics: Adult; Female; Humans; Obsessive-Compulsive Disorder; Orgasm; Phenelzine; Sexual Dysfunctions, Psych | 1987 |
Phenelzine in obsessional neurosis.
Topics: Adult; Humans; Male; Obsessive-Compulsive Disorder; Phenelzine | 1970 |
Nardil response in a chronic obsessive compulsive.
Topics: Adolescent; Adult; Child; Chlordiazepoxide; Chronic Disease; Humans; Male; Middle Aged; Obsessive-Co | 1969 |